Teva's 70+ manufacturing sites could be halved in efficiency drive
Teva could halve its manufacturing network as part of its $2bn-a-year efficiency programme says CFO Eyal Desheh, with most cuts hitting its core generics business.
Archives for June 11, 2014
Foreign execs flocking to Asia to meet growth demands, says recruiter
Local talent is not satisfying the “tremendous” demand for top-level pharma employees in Asia and recruiters are searching internationally for candidates, a pharmaceutical head-hunter has said.
Covance CFO says early stage business is mostly back on track
Sounding upbeat on Covance’s recent gains in its early stage clinical business, CFO Alison Cornell expressed a conservative amount of optimism that growth will continue.
Doubts over CDSCO claim it can assess an API supplier in 30 days
A European expert has cast doubt on a claim by Indian regulator CDSCO that it can assess and confirm the quality of an API supplier’s manufacturing operations in writing in just 30 days.
Too transparent or too opaque: EMA clinical trial data plans criticised
The EMA is being criticised on two fronts with some suggesting its trial data publication plans will drive away drug R&D while others argue the agency is backtracking in a way that will hinder public health research.
US FDA offers new supply chain security guidance
As manufacturers will have to identify illegitimate product for trading partners and the US FDA beginning next year, the agency is now offering pragmatic advice in the form of draft guidance for drugmakers regarding situations where suspect product might...